CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 35 filers reported holding CHEMBIO DIAGNOSTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $146,000 | -5.2% | 13,900 | 0.0% | 0.00% | -50.0% |
Q2 2018 | $154,000 | -22.2% | 13,900 | -44.0% | 0.00% | 0.0% |
Q1 2018 | $198,000 | -69.9% | 24,800 | -69.0% | 0.00% | -71.4% |
Q4 2017 | $657,000 | +32.2% | 80,100 | 0.0% | 0.01% | +16.7% |
Q3 2017 | $497,000 | -16.5% | 80,100 | -18.5% | 0.01% | -14.3% |
Q2 2017 | $595,000 | +14.2% | 98,300 | 0.0% | 0.01% | +16.7% |
Q1 2017 | $521,000 | -28.7% | 98,300 | -8.6% | 0.01% | -40.0% |
Q4 2016 | $731,000 | -7.7% | 107,500 | 0.0% | 0.01% | -16.7% |
Q3 2016 | $792,000 | -10.0% | 107,500 | 0.0% | 0.01% | -14.3% |
Q2 2016 | $880,000 | +36.6% | 107,500 | 0.0% | 0.01% | +27.3% |
Q1 2016 | $644,000 | +12.4% | 107,500 | 0.0% | 0.01% | 0.0% |
Q4 2015 | $573,000 | +32.0% | 107,500 | 0.0% | 0.01% | +22.2% |
Q3 2015 | $434,000 | -17.8% | 107,500 | 0.0% | 0.01% | -10.0% |
Q2 2015 | $528,000 | +23.9% | 107,500 | 0.0% | 0.01% | +11.1% |
Q1 2015 | $426,000 | +1.7% | 107,500 | 0.0% | 0.01% | -10.0% |
Q4 2014 | $419,000 | – | 107,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Penbrook Management LLC | 354,670 | $887,000 | 0.55% |
Newbridge Financial Services Group, Inc. | 61,675 | $154,000 | 0.10% |
GAGNON SECURITIES LLC | 47,793 | $119,000 | 0.02% |
Phocas Financial Corp. | 30,000 | $75,000 | 0.01% |
ROYCE & ASSOCIATES LP | 491,453 | $1,229,000 | 0.01% |
SEGALL BRYANT & HAMILL, LLC | 701,318 | $1,754,000 | 0.01% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 179,680 | $449,000 | 0.01% |
Jump Financial, LLC | 37,900 | $95,000 | 0.01% |
Cutler Group LLC / CA | 44,918 | $112,000 | 0.01% |
Virtu Financial LLC | 19,653 | $49,000 | 0.00% |